WallStreetZenWallStreetZen

NASDAQ: ESLA
Estrella Immunopharma Inc Stock

$1.24-0.01 (-0.8%)
Updated Mar 28, 2024
ESLA Price
$1.24
Fair Value Price
-$0.08
Market Cap
$45.40M
52 Week Low
$0.86
52 Week High
$33.00
P/E
-0.43x
P/B
5.02x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.36M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.04
Operating Cash Flow
-$12M
Beta
0.15
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ESLA Overview

TradeUP Acquisition Corporation is a 'blank check' company formed to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar combinations with one or more businesses. It targets the tech sector. The company was incorporated in 2021 and is based in New York, NY.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ESLA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ESLA ($1.24) is overvalued by 1,660.95% relative to our estimate of its Fair Value price of -$0.08 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ESLA ($1.24) is not significantly undervalued (1,660.95%) relative to our estimate of its Fair Value price of -$0.08 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ESLA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ESLA due diligence checks available for Premium users.

Be the first to know about important ESLA news, forecast changes, insider trades & much more!

ESLA News

Valuation

ESLA fair value

Fair Value of ESLA stock based on Discounted Cash Flow (DCF)
Price
$1.24
Fair Value
-$0.08
Undervalued by
1,660.95%
ESLA ($1.24) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ESLA ($1.24) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ESLA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ESLA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.43x
Industry
14.26x
Market
44.51x

ESLA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.02x
Industry
6.21x
ESLA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ESLA's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.0M
Profit Margin
0%
ESLA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$9.4M
Liabilities
$398.7k
Debt to equity
0.04
ESLA's short-term assets ($9.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ESLA's short-term assets ($9.45M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ESLA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.3M
Investing
$5.1M
Financing
-$6.9M
ESLA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ESLA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ESLA$45.40M-0.80%-0.43x5.02x
QNCX$45.44M-6.19%-1.39x0.55x
BCTX$45.71M+7.12%-3.58x-5.66x
TARA$45.85M+0.25%-1.12x0.67x
CALC$44.68M-0.72%-0.54x5.48x

Estrella Immunopharma Stock FAQ

What is Estrella Immunopharma's quote symbol?

(NASDAQ: ESLA) Estrella Immunopharma trades on the NASDAQ under the ticker symbol ESLA. Estrella Immunopharma stock quotes can also be displayed as NASDAQ: ESLA.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.

What is the 52 week high and low for Estrella Immunopharma (NASDAQ: ESLA)?

(NASDAQ: ESLA) Estrella Immunopharma's 52-week high was $33.00, and its 52-week low was $0.86. It is currently -96.24% from its 52-week high and 43.68% from its 52-week low.

How much is Estrella Immunopharma stock worth today?

(NASDAQ: ESLA) Estrella Immunopharma currently has 36,610,870 outstanding shares. With Estrella Immunopharma stock trading at $1.24 per share, the total value of Estrella Immunopharma stock (market capitalization) is $45.40M.

Estrella Immunopharma stock was originally listed at a price of $9.96 in Jul 15, 2021. If you had invested in Estrella Immunopharma stock at $9.96, your return over the last 2 years would have been -87.55%, for an annualized return of -64.72% (not including any dividends or dividend reinvestments).

How much is Estrella Immunopharma's stock price per share?

(NASDAQ: ESLA) Estrella Immunopharma stock price per share is $1.24 today (as of Mar 28, 2024).

What is Estrella Immunopharma's Market Cap?

(NASDAQ: ESLA) Estrella Immunopharma's market cap is $45.40M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Estrella Immunopharma's market cap is calculated by multiplying ESLA's current stock price of $1.24 by ESLA's total outstanding shares of 36,610,870.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.